SNDX
Syndax Pharmaceuticals, Inc.Data: 2026-09-11
Quick Stats
Sep 11, 202646.1
AI Score
HOLD0.9
Volume Ratio
Nov 02, 2026
Next Earnings
11
+ve Days (30d)
19
-ve Days (30d)
SNDX Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
SNDX Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
SNDX Options - Sort by Max open Interest (near term)
13th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SNDX Daily Out of Money Options - Sort by Max open Interest (near term)
13th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SNDX Daily In the Money Options - Sort by Max open Interest (near term)
13th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SNDX Most Active Options by Volume(near term)
13th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SNDX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
SNDX Stock Summary
Last updated Sep 11, 2026
SNDX is currently trading at $18.18, positioned below its 200-day moving average of $21.01, suggesting bearish momentum. The stock has a 52-week range of $12.99 to $25.59.
Technical Analysis: The 50-day moving average stands at $20.76, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 35.379, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.033, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates SNDX at 46.1/100 with a HOLD recommendation.
SNDX (Syndax Pharmaceuticals, Inc.) Indicators
Last updated Sep 11, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 35.379 |
| CMF (20) | -0.033 |
| ROC (10) | -9.821 |
| ADX (14) | 23.057 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.241 |
| AROONOSC (14) | -28.571 |
| WILLAMS %R (14) | -94.631 |
| MFI (14) | 38.967 |
SNDX Candlestick Patterns
Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.
| Date | Pattern | Signal | 5-Day Hit Rate | Edge vs Baseline | Sample |
|---|---|---|---|---|---|
| Sep 08 | Inverted Hammer | Bullish | 56.4% | +3.4 pts | 19834 |
| Sep 04 | Inverted Hammer | Bullish | 56.4% | +3.4 pts | 19834 |
| Aug 28 | Marubozu (bearish) (contrarian — textbook says the opposite) | Bullish | 56.2% | +3.2 pts | 30540 |
These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.
Syndax Pharmaceuticals, Inc. is below both the 50 Day and 200 Day SMA which is considered Bearish.
SNDX Moving Averages Analysis
SNDX (Syndax Pharmaceuticals, Inc.) Simple Moving Averages
Moving Averages are last updated Sep 11, 2026
| Days | MA |
|---|---|
| 10 | 19.77 |
| 20 | 19.86 |
| 30 | 19.8 |
| 50 | 20.76 |
| 100 | 20.32 |
| 200 | 21.01 |
SNDX Fundamental Analysis
| P/E (Forward) | -- |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.7 billion |
| Earnings/Share ($) | -2.38 |
| Net Profit Margin (%) | -0.8752 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.9348 |
| EPS Estimate Next Year ($) | -0.8159 |
| WallStreet Target Price ($) | 37.55 |
| Most Recent Quarter |
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.